Gilead Sciences Inc said on Tuesday it would buy a 49.9% stake in privately held Pionyr Immunotherapeutics Inc for $275 million, strengthening its cancer portfolio by securing access to two promising drugs. The...
Hikma’s major investor to exit nearly 1 bln pound stake in drugmaker
Boehringer Ingelheim, a major shareholder in Hikma Pharmaceuticals, is exiting the London-listed drugmaker by selling most of its nearly one billion pound stake to institutional investors and the rest back to the...
Piramal Pharma Solutions to acquire manufacturing facility of G&W Laboratories in US
Piramal Enterprises Ltd’s Pharma Solutions business, a contract development and manufacturing organization, on Saturday announced that it has entered into an agreement with G&W Laboratories Inc. to acquire its...
India Life Sciences Fund invests ₹140 cr in 2 firms
Healthcare services and pharma focused private equity (PE) fund, India Life Sciences Fund III, made two investments worth ₹140 crore in the lockdown period. The PE firm invested ₹70 crore each in ophthalmology hospital...
Germany takes 300 million euro stake in vaccine developer CureVac
Germany will take a stake of about 23% in unlisted biotech firm CureVac by backing a 300 million euro ($337 million) capital increase to fund the company’s further development of a COVID-19 vaccine. The move was agreed...
BR Shetty’s firm Neopharma may be offered debt recast
Lenders are looking to restructure ₹2,000 crore loans owed by embattled billionaire B.R. Shetty’s Abu Dhabi-based Neopharma Llc., including conversion of some of its debt into equity, a person aware of the matter said...
Apax, KKR and PAG in final lap for JB Chemicals buyout
Three global private equity funds have submitted their final offers to acquire JB Chemicals, one of the oldest pharmaceutical companies in India. On Wednesday, US-based fund KKR, Apax Partners and Asia’s leading fund...
Dr Reddy’s completes the acquisition of Wockhardt’s select generics, plant
Dr.Reddy’s Laboratories Ltd on Wednesday announced that it has completed the acquisition of select divisions of Wockhardt Limiteds branded generics business in India and a few other international territories of...
Cipla to acquire 22% stake in GoApptiv
Pharma major Cipla on Wednesday said it will acquire 21.85 per cent stake in GoApptiv on a fully-diluted basis in two phases. The cost of acquisition is Rs 9 crore (Rs 5.80 crore in the first stage and Rs 3.20 crore in...
AstraZeneca approaches Gilead about potential merger
AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal on record. The U.K.-based firm...
Tata Group ties up with SCTIMST for commercial production of COVID-19 testing kits
The Tata Group has entered into a partnership agreement with the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an institute of national importance, for commercial production of COVID-19...
Government to divest stake in some pharma PSUs: Goyal
The government has decided to disinvest in certain public sector undertakings (PSU) in the pharmaceutical sector, commerce and industry minister Piyush Goyal said on Sunday and invited Indian companies to use PSUs for a...
